एपीए उद्धरण

Ozeki, N., Kawaguchi, K., Fukui,, T., Fukumoto, K., Nakamura, S., Okasaka, T., & Yokoi, K. (2015). Which variables should be considered in patients with stage II and III non-small cell lung cancer after neoadjuvant therapy? Nagoya J Med Sci.

शिकागो स्टाइल उद्धरण

Ozeki, Naoki, Koji Kawaguchi, Takayuki Fukui,, Koichi Fukumoto, Shota Nakamura, Toshiki Okasaka, और Kohei Yokoi. "Which Variables Should Be Considered in Patients With Stage II and III Non-small Cell Lung Cancer After Neoadjuvant Therapy?" Nagoya J Med Sci 2015.

एमएलए उद्धरण

Ozeki, Naoki, et al. "Which Variables Should Be Considered in Patients With Stage II and III Non-small Cell Lung Cancer After Neoadjuvant Therapy?" Nagoya J Med Sci 2015.